| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 73,989 | 38,477 | 25,380 | | Cost of Revenue | 5,672 |
-
|
-
| | | Gross Profit | 68,317 | 38,477 | 25,380 | | | Operating Expenses | | Research Development | 126,678 | 142,340 | 128,450 | | Selling General and Administrative | 60,238 | 46,890 | 33,224 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (118,599) | (150,753) | (136,294) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,940 | 10,286 | 13,903 | | Earnings Before Interest And Taxes | (107,659) | (140,467) | (122,391) | | Interest Expense | 8,582 | 7,677 | 7,611 | | Income Before Tax | (116,241) | (148,144) | (130,002) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (116,241) | (148,144) | (130,002) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (116,241) | (148,144) | (130,002) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($116,241) | ($148,144) | ($130,002) |
|
1.48% Nasdaq 
Income Statement
